SyncThink, a next generation neurotechnology company, and makers of the award-winning EYE-SYNC technology, announces that it has completed CE Mark certification, affirming conformity to European Medical Device Regulation (MDR), also known as ISO 13485. EYE-SYNC will...
SyncThink, a next-gen neurotechnology company and developer of the award-winning virtual reality-based Eye-Sync technology, announced the expansion of its clinical advisory board and the creation of a specific advisory panel of physical therapy providers to assist the...
SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces the expansion of its partnership with Pico Interactive, a global technology company that develops innovative VR and enterprise solutions, and the...
The US Food and Drug Administration (FDA) has granted clearance of the EYE-SYNC technology as an Aid to Concussion, or mild Traumatic Brain Injury (mTBI) Diagnosis, SyncThink — a next gen neurotechnology company and developer of the award-winning EYE-SYNC...
SyncThink announces the addition of new software features to its EYE-SYNC platform that are designed to be used by healthy individuals to improve dynamic vision, a key characteristic of high performance in sport. The addition of these tools to the brain health...
